Answers are grounded in this paper and cite their sources.
Patients with RBN respond to bevacizumab, which can improve clinical outcomes and cognitive function. Bevacizumab appears to be more efficacious than corticosteroid-based treatment. The safety profile was comparable to that of the corticosteroids.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: